Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+41.8%
5Y CAGR+30.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+41.8%/yr
vs +18.1%/yr prior
5Y CAGR
+30.7%/yr
Recent acceleration
Acceleration
+23.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$600.34M+28.0%
2024$468.86M+58.7%
2023$295.45M+40.4%
2022$210.41M+7.8%
2021$195.18M+24.0%
2020$157.36M-7.4%
2019$169.96M+57.1%
2018$108.16M+65.4%
2017$65.40M+172.5%
2016$24.00M-